Nosebleed breakthrough? new block may beat painful packing
NCT ID NCT07421622
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will compare two methods for stopping nosebleeds in 40 adults: standard nasal packing and a greater palatine foramen block (an injection of numbing medicine). The main goal is to see which causes less pain and which controls bleeding better. Results will be measured 24 hours after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 2% lidocaine with adrenaline (local anesthetic)
- What this could lead to
- If GPFB works better, it could offer a less painful way to stop nosebleeds in the emergency room.
- What could go wrong
- This is a very small pilot study (40 people) that hasn't started yet. The block may not control bleeding as well as packing, and there are risks like allergic reaction or nerve injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPISTAXIS NOSEBLEED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.